Literature DB >> 12555943

Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis.

P T Clayton1, A Verrips, E Sistermans, A Mann, G Mieli-Vergani, R Wevers.   

Abstract

Follow-up investigations were undertaken on a previously reported patient who had severe familial giant cell hepatitis in infancy associated with substantially increased urinary excretion of bile alcohol glucuronides. By the age of 11 years, he had developed a profile of cholanoids in plasma and urine that closely resembled the pattern seen in cerebrotendinous xanthomatosis (CTX). Sequencing of the sterol 27-hydroxylase gene (CYP27A) showed that he was homozygous for a deletion (525/526delG) that causes a frameshift and a premature stop codon. This genotype has previously been described in an adult female with classical symptoms of CTX (tendon xanthomata, cataracts and deteriorating cognitive function). A review of past medical histories of a group of patients with CTX revealed that prolonged neonatal cholestatic jaundice was common. The family histories also revealed fetal and neonatal deaths among siblings of patients with CTX. We conclude that defective activity of cholesterol 27-hydroxylase can lead to neonatal cholestatic jaundice ('hepatitis of infancy'), which may be self-limiting. After a latent period, however, progressive accumulation of cholesterol and cholestanol can lead to the xanthomata, neurodegeneration, cataracts and atherosclerosis that are typical of CTX.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12555943     DOI: 10.1023/a:1021211520034

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

1.  Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy.

Authors:  S Ferdinandusse; S Denis; P T Clayton; A Graham; J E Rees; J T Allen; B N McLean; A Y Brown; P Vreken; H R Waterham; R J Wanders
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

2.  Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis.

Authors:  A Verrips; G C Steenbergen-Spanjers; J A Luyten; L P van den Heuvel; A Keyser; F J Gabreëls; R A Wevers
Journal:  Hum Genet       Date:  1996-12       Impact factor: 4.132

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Urinary bile alcohol profiles in healthy and cholestatic children.

Authors:  M Nakagawa; M Une; S Takenaka; Y Tazawa; S Nozaki; T Imanaka; T Kuramoto
Journal:  Clin Chim Acta       Date:  2001-12       Impact factor: 3.786

5.  Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency.

Authors:  P P Van Veldhoven; E Meyhi; R H Squires; M Fransen; B Fournier; V Brys; M J Bennett; G P Mannaerts
Journal:  Eur J Clin Invest       Date:  2001-08       Impact factor: 4.686

6.  Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding.

Authors:  M Schwarz; D W Russell; J M Dietschy; S D Turley
Journal:  J Lipid Res       Date:  2001-10       Impact factor: 5.922

7.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

8.  Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha.

Authors:  C Song; S Liao
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

9.  Familial giant cell hepatitis with low bile acid concentrations and increased urinary excretion of specific bile alcohols: a new inborn error of bile acid synthesis?

Authors:  P T Clayton; M Casteels; G Mieli-Vergani; A M Lawson
Journal:  Pediatr Res       Date:  1995-04       Impact factor: 3.756

10.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

View more
  31 in total

1.  A useful multi-analyte blood test for cerebrotendinous xanthomatosis.

Authors:  Andrea E DeBarber; Jenny Luo; Roberto Giugliani; Carolina F M Souza; John Pei-Wen Chiang; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  Clin Biochem       Date:  2014-04-21       Impact factor: 3.281

2.  Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism.

Authors:  Andrea Mignarri; Alessandro Malandrini; Marina Del Puppo; Alessandro Magni; Lucia Monti; Federica Ginanneschi; Alessandra Tessa; Filippo Maria Santorelli; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2014-02-08       Impact factor: 4.849

3.  Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment.

Authors:  Andrea E DeBarber; Limor Kalfon; Ayalla Fedida; Vered Fleisher Sheffer; Shani Ben Haroush; Natalia Chasnyk; Efrat Shuster Biton; Hanna Mandel; Krystal Jeffries; Eric S Shinwell; Tzipora C Falik-Zaccai
Journal:  J Lipid Res       Date:  2018-08-22       Impact factor: 5.922

4.  A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis.

Authors:  Andrea Mignarri; Gian Nicola Gallus; Maria Teresa Dotti; Antonio Federico
Journal:  J Inherit Metab Dis       Date:  2014-01-18       Impact factor: 4.982

5.  Cerebrotendinous Xanthomatosis Presenting with Infantile Spasms and Intellectual Disability.

Authors:  Austin Larson; James D Weisfeld-Adams; Tim A Benke; Penelope E Bonnen
Journal:  JIMD Rep       Date:  2016-11-18

6.  Nationwide survey on cerebrotendinous xanthomatosis in Japan.

Authors:  Yoshiki Sekijima; Shingo Koyama; Tsuneaki Yoshinaga; Masayoshi Koinuma; Yuji Inaba
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

7.  Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.

Authors:  H A Lemonde; E J Custard; J Bouquet; M Duran; H Overmars; P J Scambler; P T Clayton
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 8.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 9.  Diagnosis of inherited disorders of liver metabolism.

Authors:  P T Clayton
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 10.  Mechanisms of disease: Inborn errors of bile acid synthesis.

Authors:  Shikha S Sundaram; Kevin E Bove; Mark A Lovell; Ronald J Sokol
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.